JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT07603479 · RECRUITING

Trial details

NCT number: NCT07603479
Sponsor: Jecho Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignancies Solid Malignant Tumor NHL (Non-Hodgkin Lymphoma)Solid Tumor Cancer

Start date: 2026-06-25
Primary completion: 2030-05-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.